![(1S)-1-(1H-INDOL-3-YLMETHYL)-2-(2-PYRIDIN-4-YL-[1,7]NAPHTYRIDIN-5-YLOXY)-EHYLAMINE in PDB entry 2f7z, assembly 1, side view.](https://www.ebi.ac.uk/pdbe/static/entry/2f7z_entity_3_side_image-200x200.png "Hetero dimeric assembly 1 of PDB entry <span class='highlight'>2f7z</span> contains 1 copy of <span class='highlight'>(1S)-1-(1H-INDOL-3-YLMETHYL)-2-(2-PYRIDIN-4-YL-[1,7]NAPHTYRIDIN-5-YLOXY)-EHYLAMINE</span>. Side view.")
![(1S)-1-(1H-INDOL-3-YLMETHYL)-2-(2-PYRIDIN-4-YL-[1,7]NAPHTYRIDIN-5-YLOXY)-EHYLAMINE in PDB entry 2f7z, assembly 1, top view.](https://www.ebi.ac.uk/pdbe/static/entry/2f7z_entity_3_top_image-200x200.png "Hetero dimeric assembly 1 of PDB entry <span class='highlight'>2f7z</span> contains 1 copy of <span class='highlight'>(1S)-1-(1H-INDOL-3-YLMETHYL)-2-(2-PYRIDIN-4-YL-[1,7]NAPHTYRIDIN-5-YLOXY)-EHYLAMINE</span>. Top view.")
Environment details NEW
6EA 1000 bound to chain E
The above 2D and 3D (Mol*) views of ligand interactions use quaternary structure derived from the PDB entry.
Please note:
Please note:
- Some chain IDs in the tooltip are followed by a number in square brackets. This number corresponds to the operation ID (mmCIF ‘oper_expression’) used to transform the chain.
- The structure seen in Mol* (3D view) was protonated using ChimeraX.
- Interactions were calculated using Arpeggio (see details for interaction types).
- The colour scheme used is consistent with Clustal X.